Header

UZH-Logo

Maintenance Infos

Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography


Lancellotti, Patrizio; Nkomo, Vuyisile T; Badano, Luigi P; Bergler, Jutta; Bogaert, Jan; Davin, Laurent; Cosyns, Bernard; Coucke, Philippe; Dulgheru, Raluca; Edvardsen, Thor; Gaemperli, Oliver; Galderisi, Maurizio; Griffin, Brian; Heidenreich, Paul A; Nieman, Koen; Plana, Juan C; Port, Steven C; Scherrer-Crosbie, Marielle; Schwartz, Ronald G; Sebag, Igal A; Voigt, Jens-Uwe; Wann, Samuel; Yang, Phillip C (2013). Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Journal of the American Society of Echocardiography, 26(9):1013-1032.

Abstract

Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in life expectancy obtained with anti-cancer therapy can be compromised by increased morbidity and mortality associated with its cardiac complications. While radiosensitivity of the heart was initially recognized only in the early 1970s, the heart is regarded in the current era as one of the most critical dose-limiting organs in radiotherapy. Several clinical studies have identified adverse clinical consequences of radiation-induced heart disease (RIHD) on the outcome of long-term cancer survivors. A comprehensive review of potential cardiac complications related to radiotherapy is warranted. An evidence-based review of several imaging approaches used to detect, evaluate, and monitor RIHD is discussed. Recommendations for the early identification and monitoring of cardiovascular complications of radiotherapy by cardiac imaging are also proposed.

Abstract

Cardiac toxicity is one of the most concerning side effects of anti-cancer therapy. The gain in life expectancy obtained with anti-cancer therapy can be compromised by increased morbidity and mortality associated with its cardiac complications. While radiosensitivity of the heart was initially recognized only in the early 1970s, the heart is regarded in the current era as one of the most critical dose-limiting organs in radiotherapy. Several clinical studies have identified adverse clinical consequences of radiation-induced heart disease (RIHD) on the outcome of long-term cancer survivors. A comprehensive review of potential cardiac complications related to radiotherapy is warranted. An evidence-based review of several imaging approaches used to detect, evaluate, and monitor RIHD is discussed. Recommendations for the early identification and monitoring of cardiovascular complications of radiotherapy by cardiac imaging are also proposed.

Statistics

Citations

59 citations in Web of Science®
81 citations in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2013
Deposited On:06 Feb 2014 11:56
Last Modified:08 Dec 2017 03:21
Publisher:Elsevier
ISSN:0894-7317
Publisher DOI:https://doi.org/10.1016/j.echo.2013.07.005
PubMed ID:23998694

Download

Full text not available from this repository.
View at publisher